BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 30, 2003
View Archived Issues
Shire BioChem scientists report new agents for hepatitis C virus
Read More
Novel antifungal macrolides isolated and tested by Ajinomoto scientists
Read More
Calcium antagonists and their use in IBS reported by Ajinomoto
Read More
Ono identifies novel cysteine protease inhibitors
Read More
Boehringer Ingelheim claims new cathepsin inhibitors for osteoporosis, arthritis, etc.
Read More
HMG-CoA-inhibitory simvastatin analogues covered by Ranbaxy patent
Read More
New CRF1 receptor modulators and their use in anxiety, depression and bowel disorders
Read More
Allosteric AMPA modulators discovered by Boehringer Ingelheim researchers
Read More
Phase II Liprostin study cleared to begin
Read More
GTx and Wyeth enter agreement for VSV-based therapeutics and vaccines
Read More
Genome Therapeutics and MerLion form antiinfective drug discovery collaboration
Read More
Solvay and Innogenetics extend research collaboration
Read More
Epicyte advances production of human HIV antibodies in plants
Read More
NicOx and Biolipox expand research on NO-donating respiratory drugs
Read More
Tarceva phase III trial in pancreatic cancer achieves target enrollment
Read More
AlphaRx acquires exclusive rights to VT-1
Read More
Alliance and Baxter to restructure Oxygent agreement
Read More
High-affinity sigma receptor ligand SSR-125392A effective in animal models of GVHD and RA
Read More
Ref-1/AP-1 validated as therapeutic target for asthma in recent PNAS article
Read More
FDA issues complete response letter for Aldurazyme
Read More
U.S. phase II trial of antibody targeting IL-15 cleared
Read More
First clinical study of IPL-512602 under way in the U.S.
Read More
Second filing announced for YM-905
Read More
Amylin acquires rights to GLP-1 program from Restoragen
Read More
Triangle now part of Gilead
Read More